Home » Topics » BioWorld Science

BioWorld Science
RSS

RNA delivery improves CF symptoms

Aug. 7, 2018

Retinoic acid has role in fragile X

Aug. 7, 2018

Phase II study of telacebec in tuberculosis begins

Aug. 6, 2018

First patient dosed in extension cohort of amcure's phase I/Ib study of AMC-303

Aug. 6, 2018

Regeneron, bluebird bio to jointly discover immune cell therapies for cancer

Aug. 6, 2018

XinXiang Medical University divulges ANO5-targeting siRNAs

Aug. 6, 2018

Rodin Therapeutics presents HDAC1 and HDAC2 inhibitors

Aug. 6, 2018

U.S. researchers patent Nampt activators

Aug. 6, 2018

Global collaboration to develop first-in-class gene therapy for cystic fibrosis

Aug. 6, 2018

Potential mechanism of purinergic receptor-mediated remyelination discovered

Aug. 6, 2018

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...